| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 137061-48-4 | 腺苷酸环化酶激活肽-38(抗原) | H-HIS-SER-ASP-GLY-Ile-PHE-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-Lys-GLN-MET-ALA-Val-Lys-Lys-TYR-LEU-ALA-AL; H-HIS-SER-ASP-GLY-Ile-PHE-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-Lys-GLN-MET-ALA-Val-Lys-Lys-TYR-LEU-ALA-ALA-Val-LEU-GLY-Lys-Arg-TYR-Lys-GLN-Arg-Val-Lys-ASN-Lys-NH2; HIS-SER-ASP-GLY-Ile-PHE-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-Lys-GLN-MET-ALA-Val-Lys-Lys-TYR-LEU-ALA-ALA-Val-LEU-GLY-Lys-Arg-TYR-Lys-GLN-Arg-Val-Lys-ASN-Lys-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; ADENYLATE CYCLASE ACTIVATING PEPTIDE-38; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38; PACAP (1-38), AMIDE, HUMAN, OVINE, RAT; PACAP (1-38), HUMAN, OVINE, RAT; PACAP (1-38) (HUMAN, SHEEP, RAT) | 无 | C203H331N63O53S1 | 详情 | 供应商 |
| 83139-29-1 | PTH (1-34) AMIDE (HUMAN) | H-SER-Val-SER-GLU-Ile-GLN-LEU-MET-HIS-ASN-LEU-GLY-Lys-HIS-LEU-ASN-SER-MET-GLU-Arg-Val-GLU-TRP-LEU-AR; H-SER-Val-SER-GLU-Ile-GLN-LEU-MET-HIS-ASN-LEU-GLY-Lys-HIS-LEU-ASN-SER-MET-GLU-Arg-Val-GLU-TRP-LEU-Arg-Lys-Lys-LEU-GLN-ASP-Val-HIS-ASN-PHE-NH2; PTH (1-34) AMIDE (HUMAN); 1-34-Human pth amide; 1-34-Human pth-nh2; Hpth-(1-34)-nh2; Human parathyroid hormone (1-34) amide; L-Phenylalaninamide, L-seryl-L-Valyl-L-seryl-L-alpha-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-Lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-alpha-glutamyl-L-Arginyl-L-Valyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-Arginyl-L-Lysyl-L-Lysyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-Valyl-L-histidyl-L-asparaginyl- | 无 | C181H292N56O50S2 | 详情 | 供应商 |
| 198694-74-5 | H-Lys-Arg-Arg-TRP-Lys-Lys-ASN-PHE-Ile-ALA-Val-NH2; MYOSIN LIGHT CHAIN KINASE INHIBITOR; MYOSIN LIGHT CHAIN KINASE (342-352) AMIDE; MLCK INHIBITOR PEPTIDE; H-Lys-Arg-Arg-TRP-Lys-Lys-ASN-PHE-Ile-ALA-Val-NH2; Lys-Arg-Arg-TRP-Lys-Lys-ASN-PHE-Ile-ALA-Val-NH2 | ![]() | C68H113N23O12 | 详情 | 供应商 | |
| 475221-20-6 | AC-RIYKGVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNS-NH2; Arg-Ile-TYR-Lys-GLY-Val-Ile-GLN-ALA-Ile-GLN-Lys-SER-ASP-GLU-GLY-HIS-PRO-PHE-Arg-ALA-TYR-LEU-GLU-SER-GLU-Val-ALA-Ile-SER-GLU-GLU-LEU-Val-GLN-Lys-TYR-SER-ASN-SER-NH2; AC-RIYKGVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNS-NH2; NEP1-40; NOGO-66 (1-40); NOGO-66 (1-40) ANTAGONIST PEPTIDE; NOGO EXTRACELLULAR PEPTIDE, 1-40; M.W. 4625.11 C206H324N56O65 | ![]() | C206H324N56O65 | 详情 | 供应商 | |
| 112955-31-4 | ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS- | ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-; PTH-RP (HUMAN, 1-34 AMIDE) (RAT, MOUSE); PARATHYROID HORMONE RELATED PROTEIN (HUMAN, 1-34 AMIDE) (RAT, MOUSE); ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA-NH2; HYPERCALCEMIA OF MALIGNANCY FACTOR*FRAGM ENT 1-34 AM; ala-Val-ser-glu-his-gln-leu-leu-his-asp-Lys-gly-Lys-ser-Ile-gln-asp-leu-Arg-Arg-Arg-phe-phe-leu-his-his-leu-Ile-ala-glu-Ile-his-thr-ala-nh2; Parathyroid hormone-related protein (1-34) Amide, PTHrP (1-34) amide, Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2; Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human) | 无 | C180H288N58O47 | 详情 | 供应商 |
| 112540-82-6 | ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA; ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA; ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-Val-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-ALA-GLU-Ile-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |